ArticleMolecular therapy. Advances2026

i.c.v. delivery of AAV9-synapsin-promoted caveolin-1 attenuates neuromuscular deficits and neuromuscular degeneration in hSOD1

Noriyuki Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.